Ridgeback Capital Investments L.P. 13D/13G Filings for LENZ Therapeutics, Inc. (LENZ)

Ridgeback Capital Investments L.P. 13D and 13G filings for LENZ Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-07-29
4:12 pm
Purchase
2024-07-1713GLENZ Therapeutics, Inc.
LENZ
Ridgeback Capital Investments L.P.1,951,875
7.200%
1,951,875increase
(New Position)
Filing